๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current status of stem cell transplantation for multiple myeloma

โœ Scribed by Morie A. Gertz; Martha Q. Lacy; Angela Dispenzieri; Suzanne Hayman

Book ID
107531891
Publisher
Springer
Year
2005
Tongue
English
Weight
428 KB
Volume
6
Category
Article
ISSN
1527-2729

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The role of stem cell transplantation in
The role of stem cell transplantation in multiple myeloma
โœ Jean-Luc Harousseau; Michel Attal ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 193 KB

High-dose therapy with autologous stem cell transplantation (ASCT) has been extensively used in the past 15 years in multiple myeloma. The IFM 90 trial has shown that autologous bone marrow transplantation (BMT) is superior to conventional chemotherapy in terms of response rate, event free survival,

Symptom burden after autologous stem cel
Symptom burden after autologous stem cell transplantation for multiple myeloma
โœ Erica Campagnaro; Rima Saliba; Sergio Giralt; Linda Roden; Floralyn Mendoza; Ana ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB

## Abstract ## BACKGROUND Multiple myeloma (MM) is the most common indication for highโ€dose chemotherapy with autologous stem cell transplantation (ASCT) in the U.S. and can be associated with substantial morbidity. Thorough assessment and understanding of symptoms and risk factors for symptom dev